| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b09f893b262cefd50c5e76c4b85d1c0a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-006 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-10 |
| filingDate |
1999-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d588c2bb9b5aeb1ee03d58f270a9e3f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e98d436a0c34f636da211b2a584d758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf1ded2de870cb2f35ec64e84e74bff3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f88c510eb100176d0c22dd24b6be8670
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3623e783c415387320f6afd9cbbb8a5e |
| publicationDate |
2004-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6780634-B1 |
| titleOfInvention |
Method for producing (1R,4S)-2-azabicyclo[2.2.1]-hept-5-en-3-on derivatives |
| abstract |
A biotechnological method is described for preparing compounds of the general formulaswherein R<1 >is acyl or acyloxy and R<2 >is a hydrogen atom or C1-10 alkyl, comprising the conversion of a lactam of the general formulaby means of a hydrolase in the presence of a nucleophile and in the presence of a base in a constant pH range.Also described is the subsequent conversion of the compound of general formula I into the optically active 1-amino-4-(hydroxymethyl)-2-cyclopentene of the formula |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7417153-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7459301-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007043225-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006166308-A1 |
| priorityDate |
1998-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |